U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H38F2N2O5S2
Molecular Weight 632.781
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-5672

SMILES

CCN(C1CCN(CC[C@H](C2=CC=C(C=C2)S(C)(=O)=O)C3=CC(F)=CC(F)=C3)CC1)C(=O)CC4=CC=C(C=C4)S(C)(=O)=O

InChI

InChIKey=SCXSQUUTGCWHFU-WJOKGBTCSA-N
InChI=1S/C32H38F2N2O5S2/c1-4-36(32(37)19-23-5-9-29(10-6-23)42(2,38)39)28-13-16-35(17-14-28)18-15-31(25-20-26(33)22-27(34)21-25)24-7-11-30(12-8-24)43(3,40)41/h5-12,20-22,28,31H,4,13-19H2,1-3H3/t31-/m1/s1

HIDE SMILES / InChI

Molecular Formula C32H38F2N2O5S2
Molecular Weight 632.781
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 19:47:58 UTC 2023
Edited
by admin
on Fri Dec 15 19:47:58 UTC 2023
Record UNII
61XQN688TW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-5672
Common Name English
AZD5672
Code English
BENZENEACETAMIDE, N-(1-((3R)-3-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULFONYL)PHENYL)PROPYL)-4-PIPERIDINYL)-N-ETHYL-4-(METHYLSULFONYL)-
Systematic Name English
Code System Code Type Description
CAS
780750-65-4
Created by admin on Fri Dec 15 19:47:58 UTC 2023 , Edited by admin on Fri Dec 15 19:47:58 UTC 2023
PRIMARY
DRUG BANK
DB11804
Created by admin on Fri Dec 15 19:47:58 UTC 2023 , Edited by admin on Fri Dec 15 19:47:58 UTC 2023
PRIMARY
FDA UNII
61XQN688TW
Created by admin on Fri Dec 15 19:47:58 UTC 2023 , Edited by admin on Fri Dec 15 19:47:58 UTC 2023
PRIMARY
ChEMBL
CHEMBL1951914
Created by admin on Fri Dec 15 19:47:58 UTC 2023 , Edited by admin on Fri Dec 15 19:47:58 UTC 2023
PRIMARY
SMS_ID
100000175721
Created by admin on Fri Dec 15 19:47:58 UTC 2023 , Edited by admin on Fri Dec 15 19:47:58 UTC 2023
PRIMARY
PUBCHEM
16007088
Created by admin on Fri Dec 15 19:47:58 UTC 2023 , Edited by admin on Fri Dec 15 19:47:58 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Did not reported any cardiovascular risk, but it was failed because of unclear reasons in a phase IIb study for rheumatoid arthritis.
Ki
Related Record Type Details
ACTIVE MOIETY